Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

SELLAS Life Sciences (SLS) Interest & Investment Income (2023 - 2024)

SELLAS Life Sciences (SLS) has disclosed Interest & Investment Income for 5 consecutive years, with $181000.0 as the latest value for Q4 2024.

  • Quarterly Interest & Investment Income rose 341.46% to $181000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $632000.0 through Dec 2024, up 81.61% year-over-year, with the annual reading at $1.4 million for FY2025, 123.26% up from the prior year.
  • Interest & Investment Income for Q4 2024 was $181000.0 at SELLAS Life Sciences, down from $221000.0 in the prior quarter.
  • The five-year high for Interest & Investment Income was $221000.0 in Q3 2024, with the low at $41000.0 in Q4 2023.